Literature DB >> 22278130

Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches.

Cristóbal Aguilar-Gallardo1, Emily Cecilia Rutledge, Ana M Martínez-Arroyo, Juan José Hidalgo, Santiago Domingo, Carlos Simón.   

Abstract

Understanding the genetic and molecular mechanisms of ovarian cancer has been the focus of research efforts working toward the greater goal of improving cancer therapy for patients with residual disease after initial treatment with conventional surgery and neoadjuvant chemotherapy. The focus of this review will be centered on new therapeutic strategies based on Cancer Stem Cells studies of chemoresistant subpopulations, the prevention of metastasis, and individualized therapy in order to find the most successful combination of treatments to effectively treat human ovarian cancer. We reviewed recent literature (1993-2011) of novel treatment approaches to ovarian cancer stem cells. As the focus of ovarian cancer investigation has centered on the cancer stem cell model and the complexities that it presents in the development of effective treatments, the future of treating ovarian cancer lies in utilizing individualized treatment systems that include enhancing existing treatments, aiming for novel therapy targets, managing the plasticity of stem cells to induce cellular differentiation, and regulating oncogenic signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22278130     DOI: 10.1007/s12015-011-9344-5

Source DB:  PubMed          Journal:  Stem Cell Rev Rep        ISSN: 2629-3277            Impact factor:   5.739


  171 in total

Review 1.  Ovarian surface epithelium: biology, endocrinology, and pathology.

Authors:  N Auersperg; A S Wong; K C Choi; S K Kang; P C Leung
Journal:  Endocr Rev       Date:  2001-04       Impact factor: 19.871

2.  Specific unsaturated fatty acids enforce the transdifferentiation of human cancer cells toward adipocyte-like cells.

Authors:  Antonio Ruiz-Vela; Cristóbal Aguilar-Gallardo; Ana M Martínez-Arroyo; Mario Soriano-Navarro; Verónica Ruiz; Carlos Simón
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

3.  CD24 is a novel predictor for poor prognosis of hepatocellular carcinoma after surgery.

Authors:  Xin-Rong Yang; Yang Xu; Bin Yu; Jian Zhou; Jia-Chu Li; Shuang-Jian Qiu; Ying-Hong Shi; Xiao-Ying Wang; Zhi Dai; Guo-Ming Shi; Bin Wu; Li-Ming Wu; Guo-Huan Yang; Bo-Heng Zhang; Wen-Xin Qin; Jia Fan
Journal:  Clin Cancer Res       Date:  2009-08-25       Impact factor: 12.531

4.  Immunohistochemical features of CD133 expression: association with resistance to chemoradiotherapy in rectal cancer.

Authors:  Susumu Saigusa; Koji Tanaka; Yuji Toiyama; Takeshi Yokoe; Yoshinaga Okugawa; Aya Kawamoto; Hiromi Yasuda; Yuki Morimoto; Hiroyuki Fujikawa; Yasuhiro Inoue; Chikao Miki; Masato Kusunoki
Journal:  Oncol Rep       Date:  2010-08       Impact factor: 3.906

Review 5.  Cellular stress response and apoptosis in cancer therapy.

Authors:  I Herr; K M Debatin
Journal:  Blood       Date:  2001-11-01       Impact factor: 22.113

6.  Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression.

Authors:  Pedro C Lara; Marta Lloret; Bernardino Clavo; Rosa M Apolinario; Luis Alberto Henríquez-Hernández; Elisa Bordón; Fausto Fontes; Agustín Rey
Journal:  Radiat Oncol       Date:  2009-08-06       Impact factor: 3.481

7.  Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.

Authors:  Koji Morimoto; Seung Jin Kim; Tomonori Tanei; Kenzo Shimazu; Yoshio Tanji; Tetsuya Taguchi; Yasuhiro Tamaki; Nobuyuki Terada; Shinzaburo Noguchi
Journal:  Cancer Sci       Date:  2009-03-09       Impact factor: 6.716

8.  Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.

Authors:  Tatsuhiko Shigeto; Yoshihito Yokoyama; Bing Xin; Hideki Mizunuma
Journal:  Oncol Rep       Date:  2007-10       Impact factor: 3.906

Review 9.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694

10.  Ovarian cancer: a clinical challenge that needs some basic answers.

Authors:  Kate Lawrenson; Simon A Gayther
Journal:  PLoS Med       Date:  2009-02-03       Impact factor: 11.069

View more
  21 in total

1.  Dual Src and MEK Inhibition Decreases Ovarian Cancer Growth and Targets Tumor Initiating Stem-Like Cells.

Authors:  Kibeom Jang; Hyunho Yoon; Karina E Hew; Fiona Simpkins; Minsoon Kim; Diana J Azzam; Jun Sun; Dekuang Zhao; Tan A Ince; Wenbin Liu; Wei Guo; Zhi Wei; Gao Zhang; Gordon B Mills; Joyce M Slingerland
Journal:  Clin Cancer Res       Date:  2018-06-29       Impact factor: 12.531

2.  Immunotherapy targeting folate receptor induces cell death associated with autophagy in ovarian cancer.

Authors:  Yunfei Wen; Whitney S Graybill; Rebecca A Previs; Wei Hu; Cristina Ivan; Lingegowda S Mangala; Behrouz Zand; Alpa M Nick; Nicholas B Jennings; Heather J Dalton; Vasudha Sehgal; Prahlad Ram; Ju-Seog Lee; Pablo E Vivas-Mejia; Robert L Coleman; Anil K Sood
Journal:  Clin Cancer Res       Date:  2014-11-21       Impact factor: 12.531

Review 3.  Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.

Authors:  Peyman Ranji; Tayyebali Salmani Kesejini; Sara Saeedikhoo; Ali Mohammad Alizadeh
Journal:  Tumour Biol       Date:  2016-08-26

4.  Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden.

Authors:  Khalid Abubaker; Rodney B Luwor; Ruth Escalona; Orla McNally; Michael A Quinn; Erik W Thompson; Jock K Findlay; Nuzhat Ahmed
Journal:  Front Oncol       Date:  2014-04-09       Impact factor: 6.244

5.  The stemness phenotype model.

Authors:  M H Cruz; A Sidén; G M Calaf; Z M Delwar; J S Yakisich
Journal:  ISRN Oncol       Date:  2012-08-08

6.  Short-term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden.

Authors:  Khalid Abubaker; Ardian Latifi; Rod Luwor; Simon Nazaretian; Hongjian Zhu; Michael A Quinn; Erik W Thompson; Jock K Findlay; Nuzhat Ahmed
Journal:  Mol Cancer       Date:  2013-03-27       Impact factor: 27.401

Review 7.  Role of the microenvironment in ovarian cancer stem cell maintenance.

Authors:  Jennifer Pasquier; Arash Rafii
Journal:  Biomed Res Int       Date:  2012-12-24       Impact factor: 3.411

Review 8.  Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research.

Authors:  Nuzhat Ahmed; Kaye L Stenvers
Journal:  Front Oncol       Date:  2013-09-25       Impact factor: 6.244

Review 9.  Ovarian cancer stem cells: a new target for cancer therapy.

Authors:  Qinglei Zhan; Chunmei Wang; Saiming Ngai
Journal:  Biomed Res Int       Date:  2013-01-30       Impact factor: 3.411

10.  Improvement in Isolation and Identification of Mouse Oogonial Stem Cells.

Authors:  Zhiyong Lu; Meng Wu; Jinjin Zhang; Jiaqiang Xiong; Jing Cheng; Wei Shen; Aiyue Luo; Li Fang; Shixuan Wang
Journal:  Stem Cells Int       Date:  2015-11-09       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.